Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medical Cannabis for Chronic Conditions and COVID-19
NCT03944447Phase 2Recruiting
- Sponsor
- OMNI Medical Services
- Start
- Dec 2018
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of medical cannabis in chronic pain, fibromyalgia (FM), epilepsy, hepatitis C (HCV), cancer, sponsored by OMNI Medical Services. Started Dec 2018; status: recruiting.
02
Drugs
medical cannabis
03
Conditions
chronic painfibromyalgia (FM)epilepsyhepatitis C (HCV)cancer
Beyond the preview
Go deeper on NCT03944447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03944447.